Table 2.

Treatment characteristics of all patients (n = 10).

Patient	Sex	Included phase A	Completed study	Total carnitine start, mmol/l	Lipids chol, TG start, end study mmol/l	Lactate start, end study mmol/l	IGF-1 start, end study nmol/l	HbA1c start, end study mmol/l	Glucose level phase A mmol/l mean, SD	Glucose level phase B mmol/l mean, SD	Ketone level phase A mmol/l mean, SD	Ketone level phase B mmol/l mean, SD	Time on KD days	Diet after study Type of diet	OS months	Age years
1	M	Yes	No	50.9	Chol: 6.20 TG: 0.82	1.2	16.7	36	4.5 (NA)	–	3.50 (NA)	–	15	–	18.4	65.5
2	M	Yes	No	33.2	Chol: 4.3 TG: 0.77 Chol: 4.6 TG: 0.88	2.4 0.9	–	32 31	4.6 (0.31)	5.4 (0.76)	4.98 (0.87)	3.14 (0.83)	96	Modified Atkins Diet	9.76	41.2
3	M	Yes	Yes	57.9	Chol: 5.2 TG: 1.81 Chol: 4.7 TG: 1.06	1.2 0.7	17.2 21.9	33 23	4.6 (0.78)	5.0 (0.70)	4.84 (1.07)	3.69 (1.15)	97	KD-MCT	19.02	36.4
4	M	Yes	Yes	28.6	Chol: 3.9 TG: 1.07 Chol: 4.7 TG: 2.41	1.2 1.3	30.4 17.9	29 25	4.4 (0.66)	5.4 (0.81)	4.97 (0.83)	2.44 (1.03)	97	KD-MCT	12.32	33.5
5	M	Yes	Yes	34.1	Chol: 5.9 TG: 1.65 Chol: 5.9 TG: 1.48	1.8 1.2	12.4 13.2	39 31	4.8 (0.72)	5.4 (0.57)	5.39 (1.05)	2.51 (0.98)	98	Modified Atkins Diet	15.31	53.1
6	F	Yes	No	21.3	Chol: 6.5 TG: 1.16	0.90	17.9	36	4.6 (0.71)	5.3 (0.30)	3.50 (0.65)	1.38 (0.77)	65	Modified Atkins Diet	9.89	62.9
7	M	No	No	31.6	Chol: 4.7 TG:0.83	1.5	7.2	–	–	–	–	–	–	–	10.32	55.8
8	M	Yes	Yes	44.5	Chol: 4.7 TG: 1.61 Chol: 3.9 TG: 1.92	– 0.9	20.6 35.9	40 29	4.7 (0.84)	5.8 (0.59)	4.47 (1.07)	3.10 (1.09)	99	Modified Atkins Diet	11.10	59.8
9	M	Yes	Yes	51.4	Chol: 5.8 TG: 0.75 Chol: 7.4 TG: 1.80	1.3 –	15.5 20.0	38 31	5.2 (0.47)	5.0 (0.53)	3.11 (0.66)	3.27 (1.20)	95	KD-MCT	17.71	53.8
10	M	Yes	Yes	34.4	Chol: 5.9 TG: 0.66 Chol: 6.0 TG: 1.52	0.7 1.0	22.0 16.8	34 36	5.0 (0.63)	5.0 (0.74)	3.28 (0.84)	2.19 (0.58)	104	KD-MCT	12.78	55.5

Legenda:

Chol, cholesterol; F, female; HbA1c, glycated hemoglobulin; IGF-1, insulin growth factor 1; KD, ketogenic diet; M, male; MCT, medium-chain triglycerides; NA, not applicable; OS, overall survival; TG, triglyceride.